Abstract
Although Brevibacterium species used to be considered as nonpathogenic microorganisms until recently, it seems that they can cause a wide variety of clinical diseases by acting mostly as opportunistic pathogens. The present case is the second reported case of infective endocarditis by Brevibacterium species; however, it is the first reported infected native aortic valve in an immunocompetent patient.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Actinomycetales Infections / diagnosis*
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / therapeutic use
-
Aortic Valve* / microbiology
-
Brevibacterium*
-
Drug Therapy, Combination
-
Endocarditis, Bacterial / diagnosis*
-
Endocarditis, Bacterial / microbiology
-
Gentamicins / administration & dosage
-
Gentamicins / therapeutic use
-
Heart Valve Diseases / diagnosis*
-
Heart Valve Diseases / microbiology
-
Humans
-
Immunocompetence
-
Male
-
Middle Aged
-
Vancomycin / administration & dosage
-
Vancomycin / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Gentamicins
-
Vancomycin